Arthritic therapeutics market seen reaching $97 billion by 2030

By AI, Created 10:57 AM UTC, May 20, 2026, /AGP/ – The global arthritic therapeutics market is projected to rise from $72.44 billion in 2025 to $77 billion in 2026, then reach $97.09 billion by 2030, according to The Business Research Company. Growth is being driven by more arthritis cases, an aging population and wider use of biologics, telemedicine and digital health tools.

Why it matters: - The arthritic therapeutics market is growing as arthritis cases rise worldwide and more patients need treatment to reduce pain, inflammation and joint damage. - The market’s expansion points to continued demand for medications, physical therapy and other interventions that help patients maintain mobility and quality of life. - The shift toward biologics, digital health and personalized care could change how arthritis is managed over the next several years.

What happened: - The Business Research Company released its Global Arthritic Therapeutics Market Report 2026 on May 8, 2026. - The report values the market at $72.44 billion in 2025 and forecasts $77 billion in 2026. - The report projects the market will reach $97.09 billion by 2030. - The forecast covers markets across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report - View the full report

The details: - The market is expected to grow at a compound annual growth rate of 6.3% in 2026. - The report projects a 6.0% CAGR through 2030. - Historical growth has been supported by more arthritis cases worldwide, a growing elderly population, limited access to advanced therapies in some regions, higher awareness of arthritis management and expanded healthcare infrastructure. - Future growth is tied to new biologic and targeted therapies, greater use of telemedicine and remote monitoring, digital health platforms and higher investment in arthritis research and clinical trials. - The report says personalized medicine is gaining importance, with more customized arthritis management plans, growth in home-based physical therapy and broader use of online pharmacies and digital distribution. - Early diagnosis and preventive care are also becoming more prominent in arthritis management. - Arthritic therapeutics include medicines, physical therapy and other interventions aimed at easing symptoms and slowing joint deterioration. - The treatments are used for conditions including osteoarthritis and rheumatoid arthritis. - Arthritis includes more than 100 conditions marked mainly by joint pain and inflammation. - A June 2024 report from the Australian Institute of Health and Welfare said about 514,000 Australians, or 2.0% of the population, were living with rheumatoid arthritis in 2022. - The same report said rheumatoid arthritis accounted for 2.0% of total disease burden and 16% of musculoskeletal disease burden in 2023. - North America held the largest share of the arthritic therapeutics market in 2025. - North America’s lead is tied to advanced healthcare infrastructure, high awareness and strong research and development investment.

Between the lines: - The market outlook suggests arthritis care is moving beyond symptom relief toward more continuous, digitally supported and individualized treatment models. - North America’s lead indicates that reimbursement, infrastructure and research capacity continue to shape where advanced therapies gain traction fastest. - The report’s emphasis on telemedicine, online pharmacies and home-based therapy reflects a broader healthcare shift toward lower-friction access and long-term disease management.

What’s next: - The market is on track to keep expanding through 2030 if current drivers hold. - New drug development, clinical research and digital delivery models are likely to shape competition in the category. - Providers and patients may see broader use of remote monitoring and personalized care plans as part of routine arthritis treatment.

The bottom line: - Arthritic therapeutics is becoming a larger, more tech-enabled market as aging populations and rising disease prevalence increase demand worldwide.